Reduction of the Dietary Glycemic Index (GI) by L-Arabinose and Indigestible Dextrin

Effects of the Combination of L-Arabinose and Indigestible Dextrin on Glycemic Index: a Double-Blind, Crossover Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01039662

Enrollment

Registered

2009-12-25

Start date

2009-12-31

Completion date

2010-12-31

Last updated

2011-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

This study aims to investigate the effect of supplement containing L-arabinose and indigestible dextrin on dietary glycemic index.

Interventions

DIETARY_SUPPLEMENTL-arabinose and indigestible dextrin

DIETARY_SUPPLEMENTPlacebo

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

PREVENTION

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy as based on medical history and physical examination * BMI is less or equal to 30 kg/m2 * Willing not to serve as blood donor during the study * Informed consent signed

Exclusion criteria

* Impaired Glucose Tolerance * Female subjects who are pregnant or nursing a child * Participation in any clinical trial up to 90 days before Day 1 of this study * Renal or hepatic dysfunction * Heart disease * Under medication

Design outcomes

Primary

Measure	Time frame
Postprandial glucose level	2 hours

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026